Contraceptive access gaps driven by federal rollbacks, provider shortages, and stalled state legislation could be narrowed by letting trained pharmacists prescribe birth control independently.
|Articles|June 20, 2022
Daily OTC Pearl: Uqora Target
Author(s)Saro Arakelians, PharmD
Uqora Target flushes the urinary tract to help avoid urinary tract infections.
Advertisement
OTC/Lifestyle Pearl of the Day: Uqora Target
Indication: This product flushes the urinary tract to help avoid urinary tract infections.
Insight:
- Target's ingredients work to flush the urinary tract. Special ingredients alkalize the urine and may make it less acidic. The product also increases urinary flow with a diuretic. The ingredients take effect upon urination.
- If you are not sexually active, get 10 packets of Target and drink every 3 days.
- If you are sexually active, get 20 packets of Target and drink every 3 days, and immediately after sex.
- If you want maximum support: Get 30 packets of Target and drink every day.
- Mix a packet in 8-12 ounces of water. Drink Target every 3 days and after sex.
Source:
Advertisement
Related to this article
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
The data helps pharmaicts predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
CDC-recommended adult vaccination programs for pneumococcal disease, RSV, influenza, and COVID-19 prevent over 182,000 deaths and generate up to $12 in societal value for every $1 spent.
This article discusses a recent publication examining pharmacy access across Minnesota and explores the complex factors contributing to threatened community health access across the US.
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
3
Biologic Stewardship: The Next Frontier for Health System Pharmacists
4
Baseline Interferon Activity in Monocytes Predicts mRNA Vaccine Adverse Effects, Study Finds
5